MEHTA PHARMACEUTICAL INDUSTRIES

Company Description

Mehta Pharmaceuticals Industries was established in the year 1970. The company is involved in the manufacturing & export of pharmaceutical active ingredients & intermediates. The company is MEHTA PHARMACEUTICAL INDUSTRIESll established in the Indian pharmaceutical industry with a group turnover of 700 million Indian rupees and has now set its eyes on the global market.
The company has state-of-the-art plant facilities at Thane in the state of Maharashtra equipped with strict quality control standards with a state FDA GMP certificate. This is backed by highly skilled and experienced employees in marketing and technical service areas.
The group believes in Quality, Customer Service & Product Development through innovative inputs. The company is supplying to the top multinationals in India for the past decade satisfying them with the superior and consistent quality and on-time delivery. The company is already operating in various other countries besides India and has received three export awards from CHEMEXCIL for export performance and is also a goverment recognised export house.
We are committed to marketing and supplying quality products and services to meet the growing diversity of consumer needs. We are committed to our clients assuring satisfaction in quality and service through continuous market research, analysis and making ourselves accessible to our clients.
At Mehta Pharmaceutical Industries our motto is
"Customer Satisfaction Come First".

Company Information

  • Contact Person:Mr. Atul Mehta
  • Department:Director/CEO/General Manager
  • Job Title:Director
  • Telephone:
  • Mobile Phone:
  • Fax:
  • Zip:400053
  • Province/State:Maharashtra
  • City:Off, Veera Desai Roa
  • Operational Address:313 - 314, 315 Janki Centre 29, Shah Industrial EstateOff Veera Desai Road,, Mumbai, Maharashtra, India
  • Business Type:Manufacturer
  • Year Established:1970
  • Year Start Exporting:1980
  • Number Of Employees:51 - 100 People
  • Total Revenue:US$50 Million - US$100 Million
  • Average Lead Time:15 Day(s)
  • Trade Capacity:Domestic Market : 7.00% South Asia : 7.00%
  • Production Capacity:Factory Size : 3,000-5,000 square meters No. of Pr
  • R&D Capacity:No. of R&D Staff :5 - 10 People
  • Main Products:Azithromycin Dihydrate,Erythromycin Base, Erythromycin Ethyl Succinate, Erythromycin Estolate, Erythromycin Stearate, Laboratory Reagent,Bronchodilator, Anti Pruritic, Anti Septic,Anti Emetic, Antihypertensives,Antibacterial
  • Address:313-314, Janki Centre Plot no. 29, Shah Industrial Estate
  • Main Markets:Domestic Market, South Asia, Southern Europe, Nort
  • Location:Maharashtra, India
  • Website:Visit website

Product

  • Azithromycin Dihydrate
  • Chloramphenicol Base
  • Chloramphenicol Palmitate
  • Erythromycin Stearate
  • Erythromycin Estolate
  • Erythromycin Base
  • Erythromycin Ethylsuccinate
  • Chloramphenicol
  • Clarithromycin
  • Erythromycin Propionate
  • Bisoprolol Hemifumarate
  • Prochlorperazine Maleate
  • Prochlorperazine Mesylate
  • Amoxapine USP
  • Promethazine Theoclate
  • Chlorhexidine Gluconate
  • Calamine IP/BP
  • AMINOPHYLLINE
  • Potassium Iodide
  • MALEIC ACID
  • Silver Iodide
  • Azithromycin Dihydrate IP/USP
  • Chloramphenicol Base IP/BP/USP
  • Chloramphenicol Palmitate IP/BP/USP
  • Erythromycin Estolate IP/BP/USP
  • Erythromycin Base IP/BP/USP
  • Erythromycin Ethylsuccinate BP/USP
  • Erythromycin Stearate IP/BP/USP
  • AMINOPHYLLINE IP/BP
  • MALEIC ACID BP
  • AMINOPHYLLINE IP / BP
  • Prochlorperazine Mesylate IP/BP
  • Prochlorperazine Maleate IP / BP / USP
  • Potassium Iodide AR/LR
  • Promethazine Theoclate IP/BP
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries